ReviewESMO real world data and digital oncology2026
Reporting of National Cancer Registry statistics in Europe: a scoping review.
Review in ESMO real world data and digital oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Population-based cancer registries (PBCRs) play an important role in national cancer control programs by providing data for cancer statistics. The European Network of Cancer Registries (ENCR) aims to promote the impact and use of European PBCRs and umbrella organizations (UOs). This study maps the reporting practices of European national PBCRs (NPBCRs) and UOs regarding the key statistical indicators: incidence, prevalence, and survival. Patients and methods: The ENCR Members Contact List and Google.com were used to identify websites of all NPBCRs and UOs, which were screened for sources of evidence (SoEs). Using a predefined protocol, the SoEs were assessed for the reporting of incidence, prevalence, and survival, as well as the timeliness of reporting. A scoring rubric was used to assess data accessibility. Results: Excluding microstates, at least one SoE was identified for 34 out of 45 European countries. In total, 60 SoEs containing nationwide statistics were found, mainly general cancer reports ( Conclusion: This study highlights the heterogeneity in the reporting, accessibility, and timeliness of cancer statistics across European NPBCRs and UOs. Improving harmonization and reporting practices could enhance the value of cancer registry data for cancer control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.